Germany · Question · Mündliche Frage
20/11579
Medicines for long and post-COVID patients
Introduced
31 May 2024
Last action
5 June 2024 · Mündliche Frage/Schriftliche Antwort
Status
Beantwortet
Sponsors
—
Subjects
Discovery layer
Source updated
13 January 2026
Summary
Original text of the question(s):<br /> <br /> What is the current status regarding the list of medications to be drawn up by the “Long COVID Off-Label Use” expert group that can be prescribed and paid for for long and post-COVID patients even outside of the approval, or how does the federal government assess this?
Machine translation from German. The official text remains authoritative.
Timeline
31 May 2024
Mündliche Frage
Medicines for long and post-COVID patients
Source: BT
5 June 2024
Mündliche Frage/Schriftliche Antwort
Medicines for long and post-COVID patients
Source: BT
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://dip.bundestag.de/vorgang/medikamente-fur-long-und-post-covid-patienten/312543
- Open data entity: https://search.dip.bundestag.de/api/v1/vorgang/312543
- germany · 312543 · source updated 13 January 2026